Becton Dickinson SG&A Expenses 2012-2026 | BDX
Becton Dickinson annual/quarterly sg&a expenses history and growth rate from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Becton Dickinson sg&a expenses for the quarter ending March 31, 2026 were $1.213B, a 4.71% decline year-over-year.
- Becton Dickinson sg&a expenses for the twelve months ending March 31, 2026 were $5.293B, a 4.98% increase year-over-year.
- Becton Dickinson annual sg&a expenses for 2025 were $5.278B, a 8.67% increase from 2024.
- Becton Dickinson annual sg&a expenses for 2024 were $4.857B, a 2.92% increase from 2023.
- Becton Dickinson annual sg&a expenses for 2023 were $4.719B, a 0.21% increase from 2022.
|
Becton Dickinson Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $5,278 |
| 2024 | $4,857 |
| 2023 | $4,719 |
| 2022 | $4,709 |
| 2021 | $4,719 |
| 2020 | $4,185 |
| 2019 | $4,332 |
| 2018 | $4,016 |
| 2017 | $2,909 |
| 2016 | $3,005 |
| 2015 | $2,563 |
| 2014 | $2,145 |
| 2013 | $2,422 |
| 2012 | $1,923 |
| 2011 | $1,824 |
|
Becton Dickinson Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1,213 |
| 2025-12-31 | $1,393 |
| 2025-09-30 | $1,367 |
| 2025-06-30 | $1,320 |
| 2025-03-31 | $1,273 |
| 2024-12-31 | $1,318 |
| 2024-09-30 | $1,255 |
| 2024-06-30 | $1,196 |
| 2024-03-31 | $1,193 |
| 2023-12-31 | $1,213 |
| 2023-09-30 | $1,137 |
| 2023-06-30 | $1,190 |
| 2023-03-31 | $1,205 |
| 2022-12-31 | $1,187 |
| 2022-09-30 | $1,183 |
| 2022-06-30 | $1,149 |
| 2022-03-31 | $1,192 |
| 2021-12-31 | $1,185 |
| 2021-09-30 | $1,222 |
| 2021-06-30 | $1,200 |
| 2021-03-31 | $1,148 |
| 2020-12-31 | $1,149 |
| 2020-09-30 | $1,059 |
| 2020-06-30 | $980 |
| 2020-03-31 | $1,025 |
| 2019-12-31 | $1,121 |
| 2019-09-30 | $1,094 |
| 2019-06-30 | $1,076 |
| 2019-03-31 | $1,089 |
| 2018-12-31 | $1,073 |
| 2018-09-30 | $1,101 |
| 2018-06-30 | $1,086 |
| 2018-03-31 | $1,056 |
| 2017-12-31 | $773 |
| 2017-09-30 | $757 |
| 2017-06-30 | $719 |
| 2017-03-31 | $724 |
| 2016-12-31 | $709 |
| 2016-09-30 | $797 |
| 2016-06-30 | $728 |
| 2016-03-31 | $732 |
| 2015-12-31 | $748 |
| 2015-09-30 | $757 |
| 2015-06-30 | $751 |
| 2015-03-31 | $511 |
| 2014-12-31 | $544 |
| 2014-09-30 | $561 |
| 2014-06-30 | $528 |
| 2014-03-31 | $525 |
| 2013-12-31 | $531 |
| 2013-09-30 | $877 |
| 2013-06-30 | $534 |
| 2013-03-31 | $515 |
| 2012-12-31 | $496 |
| 2012-09-30 | $484 |
| 2012-06-30 | $469 |
| 2012-03-31 | $488 |
| 2011-12-31 | $482 |
| 2011-09-30 | $466 |
| 2011-06-30 | $468 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |